Biochemistry and biomedical chemistry
Pharmacokinetics, toxicity
Pharmacokinetics follows drug exposure over time; toxicology asks how exposure relates to harmful effects.
IntuitionIntuition: the central idea
Pharmacokinetics follows drug exposure over time; toxicology asks how exposure relates to harmful effects.
SchoolSchool level: key concepts and a first application
Definition: Core concept
For a one-compartment IV bolus model, concentration decays exponentially. Oral absorption introduces an absorption phase; clearance and bioavailability shape exposure.
Absorption, distribution, metabolism and excretion (ADME) determine exposure. Toxicity can arise from parent drug, metabolites, off-target binding or cumulative exposure.
| Term | Interpretation |
|---|---|
| Half-life | Time for concentration to fall by half under exponential elimination. |
| Clearance | Volume cleared of drug per unit time. |
| Therapeutic window | A concentration range aiming to balance efficacy and toxicity. |
Example: Apply the idea
A drug has a 6 h elimination half-life and an initial concentration of 80 mg L⁻¹. Estimate concentration after 18 h in the one-compartment model.
Solution
Eighteen hours is three half-lives, so mg L⁻¹. This estimate assumes linear, first-order elimination and a constant compartment model.
UndergraduateUniversity level: quantitative description
Bioavailability scales absorbed dose reaching systemic circulation. Dose adjustments, dosing interval and clearance together set average steady-state exposure.
AdvancedAdvanced: assumptions and mechanistic detail
More realistic PK models can be multi-compartment or physiologically based; toxicology adds dose–response, time course, metabolites and organ-specific susceptibility.
ResearchResearch frontier: open questions and current practice
References
- Pharmacokinetic-Pharmacodynamic Modeling and Simulation · Peter L. Bonate, 2011
- Rowland and Tozer’s Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications · Hartmut Derendorf; Stephan Schmidt, 2019